|
|
|
Volumn 131, Issue 6, 2001, Pages 30-32
|
|
Designer drugs. What's best for patients isn't always what's best for profits.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG THERAPY;
ECONOMICS;
HUMAN;
INCOME;
ORGANIZATION AND MANAGEMENT;
PHARMACOGENETICS;
UNITED STATES;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG THERAPY;
HUMANS;
INCOME;
PHARMACOGENETICS;
UNITED STATES;
|
|
EID: 0035855542
PISSN: 00415537
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
